Home › Core › ISCC-IDs › 28CrYQRvfcJco

View ISCC-ID

Core Data

28CrYQRvfcJco
ISCC-ID - digital asset identifier
CCXczwp7hWJic-CThN6h9DfXZwi-CDL1yZaDCNba1-CRPVfmsqzmdHK
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

phase ii study of troxacitabine in chemotherapynaive patients with advanced cancer of the pancreas gastrointestinal tumors

Ledger Reference

coblo
Source Ledger/Blockchain
196326
N-th ISCC Decleration on source ledger
10c3789a5513766e127f5b90ca948ccdfd8b247212b608214e5e7936406af30b
Hash of block that includes the ISCC-DECLARATION
e7363733998919df72305be8b85703b4b4623755911897b95adc1da59ac2845b
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: Gastrointestinal tumors", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "R. Lapointe", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://academic.oup.com/annonc/article-pdf/16/2/289/328185/mdi061.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Oxford University Press (OUP)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1093/annonc/mdi061", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCXczwp7hWJic-CThN6h9DfXZwi-CDL1yZaDCNba1-CRPVfmsqzmdHK", "propertyID": "ISCC"}], "datePublished": "2005-02-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close